KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Return on Assets: 2013-2025

Historic Return on Assets for Travere Therapeutics (TVTX) over the last 11 years, with Sep 2025 value amounting to -0.05%.

  • Travere Therapeutics' Return on Assets fell 5.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.00% for FY2024, which is 36.00% down from last year.
  • Latest data reveals that Travere Therapeutics reported Return on Assets of -0.05% as of Q3 2025, which was up 47.23% from -0.10% recorded in Q2 2025.
  • Travere Therapeutics' 5-year Return on Assets high stood at 0.39% for Q2 2024, and its period low was -0.33% during Q3 2021.
  • In the last 3 years, Travere Therapeutics' Return on Assets had a median value of 0.08% in 2023 and averaged 0.12%.
  • As far as peak fluctuations go, Travere Therapeutics' Return on Assets soared by 44bps in 2023, and later slumped by 49bps in 2025.
  • Over the past 5 years, Travere Therapeutics' Return on Assets (Quarterly) stood at -0.28% in 2021, then spiked by 36bps to 0.08% in 2022, then rose by 25bps to 0.33% in 2023, then slumped by 33bps to -0.00% in 2024, then dropped by 5bps to -0.05% in 2025.
  • Its last three reported values are -0.05% in Q3 2025, -0.10% for Q2 2025, and -0.07% during Q1 2025.